Beth Israel Comprehensive Cancer Center Pharmacy — New York, New York

Beth Israel Comprehensive Cancer Center Pharmacy is a clinical research site located in New York, New York, United States 10011.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Beth Israel Comprehensive Cancer Center Pharmacy has participated in 2 clinical trials.

Therapeutic areas: Metastatic Breast Cancer, Breast Cancer.

Sponsors: Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Comprehensive Cancer Center Pharmacy?

Beth Israel Comprehensive Cancer Center Pharmacy has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Comprehensive Cancer Center Pharmacy conducted?

Beth Israel Comprehensive Cancer Center Pharmacy has 2 clinical trials on record. Their work covers Metastatic Breast Cancer, Breast Cancer.

Is Beth Israel Comprehensive Cancer Center Pharmacy accredited by Crixeo Health?

Beth Israel Comprehensive Cancer Center Pharmacy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Israel Comprehensive Cancer Center Pharmacy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.